Relationship Between Ablation Lesion Size Estimated by Ablation Index and Different Ablation Settings—an Ex Vivo Porcine Heart Study

2020 ◽  
Vol 13 (6) ◽  
pp. 965-969
Author(s):  
Shu-Tao Huang ◽  
Jian-Zeng Dong ◽  
Xin Du ◽  
Jia-Hui Wu ◽  
Rong-Hui Yu ◽  
...  
2004 ◽  
Vol 27 (7) ◽  
pp. 933-937 ◽  
Author(s):  
JOHN L. SAPP ◽  
KYOKO SOEJIMA ◽  
JOSHUA M. COOPER ◽  
LAURENCE M. EPSTEIN ◽  
WILLIAM G. STEVENSON

2017 ◽  
Vol 11 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Gert Jan Pelgrim ◽  
Taylor M. Duguay ◽  
J. Marco A. Stijnen ◽  
Akos Varga-Szemes ◽  
Sjoerd Van Tuijl ◽  
...  

2020 ◽  
Vol 6 (26) ◽  
pp. eaba4498 ◽  
Author(s):  
Shreya Goel ◽  
Guodong Zhang ◽  
Prashant Dogra ◽  
Sara Nizzero ◽  
Vittorio Cristini ◽  
...  

It is challenging to design effective drug delivery systems (DDS) that target metastatic breast cancers (MBC) because of lack of competent imaging and image analysis protocols that suitably capture the interactions between DDS and metastatic lesions. Here, we integrate high temporal resolution of in vivo whole-body PET-CT, ex vivo whole-organ optical imaging, high spatial resolution of confocal microscopy, and mathematical modeling, to systematically deconstruct the trafficking of injectable nanoparticle generators encapsulated with polymeric doxorubicin (iNPG-pDox) in pulmonary MBC. iNPG-pDox accumulated substantially in metastatic lungs, compared to healthy lungs. Intratumoral distribution and retention of iNPG-pDox varied with lesion size, possibly induced by locally remodeled microenvironment. We further used multiscale imaging and mathematical simulations to provide improved drug delivery strategies for MBC. Our work presents a multidisciplinary translational toolbox to evaluate transport and interactions of DDS within metastases. This knowledge can be recursively applied to rationally design advanced therapies for metastatic cancers.


2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
D Maselli ◽  
R D Johnson ◽  
R Szilveszter Matos ◽  
C Chiappini ◽  
P Camelliti ◽  
...  

Abstract Background The epicardium, the most external layer of the heart, is composed of a layer of epithelial cells and underlying connective tissue. Following myocardial infarction, epicardial cells are activated and provide a source of paracrine factors and progenitor cells. In the border zone of the ischaemic tissue, the activated epicardial cells support cardiac and vascular regeneration by releasing pro-angiogenic and pro-survival factors, and by differentiating towards multiple cell lineages. During this process, activated epicardial cells migrate to the site of injury where they contribute to both post-ischemic remodelling and fibrosis. There is limited knowledge of the cellular and molecular regulation of these processes in large animals and humans, in part due to the lack of robust and representative models. Purpose In this project, we developed an ex vivo 3D organotypic model derived from porcine hearts, amenable to culture, which enables structural, molecular and cellular studies of the epicardium. Methods Thin epicardial/cardiac tissue slices (EpCardio-TS) were obtained by using a vibratome to cut the first layer of tissue from the epicardial side of porcine heart cubes. Slices were cultured for up to 72h in a bioreactor that uses a 3D printed chamber connected to a control system that allows maintenance and adjustment of culture conditions, and ensures continuous media flow. Local intracellular delivery of fluorescent quantum-dots (Qdots) was performed using nanoneedle chips to track epicardial cells, whilst cell fate is visualised in 3D by performing immunofluorescence on decolourised slices. Results Intact EpCardio-TS obtained from porcine heart included a viable epicardium, expressing typical epicardial markers (wt-1, mesothelin, uroplakin), and an electrically active myocardium. Live/dead staining showed epicardial (67.8±16.2%, N=5) and myocardial (40.8±28.6%, N=3) viability, and TUNEL assay confirmed low levels of apoptosis (6.3±5.1% of wt-1+ epicardial cells N=1). Moreover, the presence of proliferating epicardial cells (PCNA+), the increase in wt-1+ cells, and the increase in epicardial gene expression (Tbx18 and TCF21) suggested that cells maintain their progenitor phenotype and undergo activation in culture. Nanoinjection of fluorescent Qdots to EpCardio-TS localized them to the wt-1+ cells on the slice surface, presenting a strategy to mark the epicardial layer. This, combined with the successful decolourisation of the slices, provides an in vitro platform to track the role of epicardial cells in cardiac remodelling and fibrosis. Conclusions EpCardio-TS represents a robust ex vivo model merging the complexity of a 3D organotypic culture with the simplicity of the in vitro culture. EpCardio-TS are amenable to culture and cell tracking, and can therefore find application in toxicology and gene therapy screening for the modulation of epicardial interactions with myocardial and non-myocardial cells of the heart.


2019 ◽  
Vol 3 (3) ◽  
pp. 211-219 ◽  
Author(s):  
Michal Jaworek ◽  
Guido Gelpi ◽  
Claudia Romagnoni ◽  
Federico Lucherini ◽  
Monica Contino ◽  
...  

EP Europace ◽  
2020 ◽  
Vol 22 (Supplement_1) ◽  
Author(s):  
C Lozano-Granero ◽  
J Moreno Planas ◽  
R Matia Frances ◽  
A Hernandez Madrid ◽  
I Sanchez Perez ◽  
...  

Abstract Funding Acknowledgements Beca de la Sección de Electrofisiología y Arritmias para formación en investigación post-residencia en centros españoles INTRODUCTION Ablation Index and Lesion Size Index are novel markers of ablation lesion quality that incorporate power (W), contact force (CF), and time (T) in a weighted formula to accurately estimate lesion size. While LSI includes system impedance (I) in the formula, this parameter is not considered for AI calculation. PURPOSE The aim of our study was to analyse the impact of I in lesion formation. METHODS Radiofrequency (RF) lesions were created on porcine myocardial slabs by using an open-tip irrigated catheter with real-time monitoring of CF (a TactiCath™ Quartz Contact Force Ablation Catheter for LSI-guided lesions and a ThermoCool® SmartTouch® Catheter for AI-guided lesions). Catheters were mounted in an articulated arm and manually maneuvered over a platform placed within a tank filled with either a low impedance medium (saline solution) or a high impedance medium (running water) with a heating pump to produce non-pulsatile flow directed perpendicularly to the myocardium surface at a rate of 5 l/min and a temperature of 37ºC. For each catheter and medium, ten lesions were performed with a CF of 20 grams and a W of 25, 30, 35 and 40 watts aiming at a LSI of 5 or a AI of 400 (recommended targets for posterior wall pulmonary vein isolation for each index). After RF delivery, the myocardium was cross-sectioned at the level of each lesion and its blanched zone was measured with a dial calliper with a 0.1 mm resolution (image, panel A). Lesion volume was calculated using width and depth, according to a validated formula (image, panel B). RESULTS No difference in application time was noted in the AI-guided lesions depending on the medium (23.8 ± 1.6s, 17.2 ± 1.4s, 13.7 ± 0.8s and 12.2 ± 0.7s for 25W, 30W, 35W and 40W, respectively) while a significant reduction in application time was noted in the LSI-guided lesions performed in a low I medium (93.8 ± 6.6 ohms; 17.9 ± 1.9s, 11.3 ± 3.7s, 9.1 ± 0.9s and 7.3 ± 0.5s for 25W, 30W, 35W and 40W) compared with those performed in a high impedance medium (132.4 ± 6.6 ohms; 27.3 ± 1.4s, 17.9 ± 2.5s, 15.5 ± 1.4 and 13 ± 1.2 for the same programmed W (p < 0.0001 for all comparisons). Both catheters showed differences in lesion size according to the I, with lower lesion volumes in the low I medium and higher lesion volumes in the high I medium. Although globally smaller in size, higher lesion volumes were noted in the AI-guided lesions compared to LSI-guided lesions in a low I medium (image, panel C). On the contrary, a better performance of the LSI-guided lesions was observed in the high I medium (image, panel D). CONCLUSIONS System impedance affected lesion size both in LSI-guided an AI-guided ablation lesions, with smaller lesions seen in a lower I medium. Further studies are needed to assess the clinical relevance of this findings in an in-vivo scenario. Abstract Figure.


2015 ◽  
Vol 112 (42) ◽  
pp. 13033-13038 ◽  
Author(s):  
Jennifer E. Cole ◽  
Nagore Astola ◽  
Adam P. Cribbs ◽  
Michael E. Goddard ◽  
Inhye Park ◽  
...  

Atherosclerosis is the major cause of cardiovascular disease (CVD), the leading cause of death worldwide. Despite much focus on lipid abnormalities in atherosclerosis, it is clear that the immune system also has important pro- and antiatherogenic functions. The enzyme indoleamine-2,3-dioxygenase (IDO) catalyses degradation of the essential amino acid tryptophan into immunomodulatory metabolites. How IDO deficiency affects immune responses during atherogenesis is unknown and we explored potential mechanisms in models of murine and human atherosclerosis. IDO deficiency in hypercholesterolemic ApoE−/− mice caused a significant increase in lesion size and surrogate markers of plaque vulnerability. No significant changes in cholesterol levels were observed but decreases in IL-10 production were found in the peripheral blood, spleen and lymph node B cells of IDO-deficient compared with IDO-competent ApoE−/− mice. 3,4,-Dimethoxycinnamoyl anthranilic acid (3,4-DAA), an orally active synthetic derivative of the tryptophan metabolite anthranilic acid, but not l-kynurenine, enhanced production of IL-10 in cultured splenic B cells. Finally, 3,4-DAA treatment reduced lesion formation and inflammation after collar-induced arterial injury in ApoE−/− mice, and reduced cytokine and chemokine production in ex vivo human atheroma cell cultures. Our data demonstrate that endogenous production of tryptophan metabolites via IDO is an essential feedback loop that controls atherogenesis and athero-inflammation. We show that the IDO pathway induces production of IL-10 in B cells in vivo and in vitro, suggesting that IDO may induce immunoregulatory functions of B cells in atherosclerosis. The favorable effects of anthranilic acid derivatives in atherosclerosis indicate a novel approach toward therapy of CVD.


Sign in / Sign up

Export Citation Format

Share Document